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Letters to the EditorDETRIMENTAL IMPACT OF
ENDOSCOPIC VEIN
HARVESTING: AWORD OF
CAUTION
To the Editor:
We read with interest the article
from Zenati and the coinvestigators1
of the Randomized On/Off Bypass
(ROOBY) trial about a secondary
analysis on the population enrolled
in such trial and reporting that endo-
scopic vein harvesting (EVH) is inde-
pendently associated with vein graft
failure and higher revascularization
rates at 1 year. Nevertheless, such
analysis yields consistent drawbacks
and its conclusions should be care-
fully interpreted.
First, the mentioned study is not
a prospective randomized trial aiming
at the analysis of the endoscopic tech-
nique versus the open approach. In
fact, it was a randomized, controlled,
single-blind study comparing patients
undergoing nonemergency coronary
artery bypass grafting, either on-
pump or off-pump. Therefore, any in-
sight about the endoscopic technique
was only obtained as a secondary
analysis. As such, as is widely known,
it may yield consistent limitations, de-
spite the corrections obtained by com-
plex statistical analysis.
Another major drawback of the
study is related to the complete lack
of information about the device used
for EVH, that is a carbon dioxide–
sealed (like the VasoView system
[Maquet Inc, Rastatt, Germany]) or
open system (like the Storz [Karl
Storz GmbH & Co KG, Tuttlingen,
Germany] or Sorin [Sorin S.p.a., Mi-
lan, Italy] system). In fact, as in any
surgical technique, it is mandatory to
describe the system used (either open
or closed) to address any proper con-
clusion. One could argue that since
the ROOBY trial was conducted in
the United States, where the Vaso-
View system is more popular, such de-
vice could have been used in the
majority of cases, albeit no proper
data are available. Nevertheless, the
authors cited a manuscript by RousouThe Journaland associates2 reporting that EVH
has a detrimental effect on the saphe-
nous vein endothelium, which may
lead to decreased graft patency and
worse patient outcomes. It is manda-
tory to stress that such article refers
exclusively to a sealed system (ie,
the VasoView system) and its related
damage.
Another critical limitation of the
study is related to the fact that residual
clot strands in EVH have been demon-
strated to occur exclusively with
sealed systems (thereby jeopardizing
graft patency) and that prehepariniza-
tion significantly reduces such risk3;
however, no patients received such
treatment according to the data pro-
vided in the ROOBY trial. It can also
be inferred from the article that there
was a high degree of variability in
terms of operators’ expertise, as the
authors themselves outlined. Finally,
no information has been provided
about the site of EVH (either the thigh
or the calf, the former being an easier
site for the endoscopic technique);
such information could have provided
considerable insights about potential
discrepancies occurring between the
size of the graft used and the target
vessel.
Therefore, given the aforemen-
tioned flaws, a conclusive statement
about the detrimental impact of EVH
on graft patency should not be drawn
based on the results from the ROOBY
trial.
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Bisleri, Cheema, and Muneretto
take objection to the conclusion of
our study1 and propose that a ‘‘conclu-
sive statement about the detrimental
impact of EVH [endoscopic vein har-
vesting] on graft patency should not
be drawn based on the results from
the ROOBY trial.’’ The issue of com-
promised late vein graft patency asso-
ciated with EVH was first raised by
the PREVENT-IV Investigators in
their 2009 report (1-year vein graft pa-
tency: EVH ¼ 76% vs open ¼
81%).2 Subsequently, Puskas and as-
sociates3 confirmed this finding in
their subanalysis of the EPIC trial (9
months of vein graft patency:
EVH ¼ 79% vs open ¼ 91%). Our
study was approved by the Veterans
Affairs Cooperative Studies Program
(CSP) #517 Executive Committee in
2002 as a preapproved subanalysis of
the ROOBY trial4 because of a poten-
tial safety concern with EVH. The
findings we reported (1-year vein graft
patency: EVH ¼ 74% vs open ¼
86%) fit within the existing literature
and are meant to provide a word of
caution related to using the EVH ap-
proach. We have already acknowl-
edged all of the limitations of our
analyses raised by Bisleri, Cheema,
and Muneretto in the ‘‘Methods’’ and
‘‘Discussion’’ sections of our report.
We believe that this timely letter pro-
vides additional support to the need
for future rigorous randomized con-
trolled trials: we are currently in the
advanced planning phase for a large,
multicenter randomized controlledry c Volume 142, Number 2 481
